{"name":"Alizé Pharma","slug":"aliz-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AZP-531","genericName":"AZP-531","slug":"azp-531","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AZP-531","genericName":"AZP-531","slug":"azp-531","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOSXc4TVA1SXJSS2owTzhDdlF4bTR3V1VZTWhVclh4X1lTNzBqdHp0alFpU0tucm84VjBROS1PSndwcG9zU3FYWW9zVnp0dWVwTDAza1lLMkRTcGhEOEkza1hmdWlfSFY3WFZvd2tiSmdGcVN5dGNnQlYtZjdnSXJnSnp3TTctalFacDl6X0lLTDJrbTRpamxLajR5UDY4TjlTV0tDNzdaSTdVRU0tYkdZNjNIcE5aMDFpN1o3NDBjUF8ya0xMX291dHBMdUpRN1N2enZxOVZtWnJkZWoySEx5UGhudExjM1R4dnNNb3hGdEdOUi1WOFYwS3cyYmozQQ?oc=5","date":"2025-12-11","type":"pipeline","source":"businesswire.com","summary":"Azafaros Further Strengthens Its Board of Directors With Appointment of Biotech Entrepreneur Dr. Thierry Abribat - businesswire.com","headline":"Azafaros Further Strengthens Its Board of Directors With Appointment of Biotech Entrepreneur Dr. Thierry Abribat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNcjR6VWxUSlNHaEpTWEpxeEtLTjV2aHNYRTJoN1lwdFItN05DSVhnTm1CV2VrRmhlMmtzTnUwRmpuUWJfa09LZ3NHUE5iRm9vUmdHbWhFVHk5Z3ZRMFFULXh4SVJ6QjRBRjBMWmw5clVSNkdURWNabTNzcEZlSEN6YUZDQTA2N2haTzdWVUZSMElFYmtndGktc3Z5UUZVVElCbGpURWE4eUtxeHpSNTN3VVNQVDN1aUt4RXc?oc=5","date":"2025-07-07","type":"pipeline","source":"prnewswire.com","summary":"Nuevocor Strengthens Board with Appointment of Thierry Abribat - prnewswire.com","headline":"Nuevocor Strengthens Board with Appointment of Thierry Abribat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSVRLaU12Q2c5cFIxQ00zT0hxQndnZEdza0JBbGJMb1BHTFFTd013Z051OHVpYVlUSUNrRjQyRzFCTldTRGZZM2lhZnhqQS1OUjB2WWp6X2lPcEFKVlc4QzduU0lRM1FaYzktRzk4clp5OHBYbUVreUF1NWt4QnJpdmxfbm9DdVB0WVhMTTUyTldrb0xuX2I5N2JqWThnLU5KNjJjeFFEdjhXQQ?oc=5","date":"2025-03-27","type":"regulatory","source":"Fierce Pharma","summary":"Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR - Fierce Pharma","headline":"Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOem9NZk9GN2VwU1NiY2xJYzE4YmI1RWphVzM0YUQwVGlYdVkzMnVfODBCY01FSDh6d3VrMEdZOFpVWVQtX1F2WWFhMFh1a3Q0TVd3Ni1oaUllcU45YmNGUFFKWGd4ZFQzeHNGeDMxYklhX3h6Uzh0a1BxaWFsaE1TMW5qdVYtTG5rejdCOG4zbGN5bHBWdHZwZjI0eklDS0hZ?oc=5","date":"2022-03-25","type":"pipeline","source":"Manufacturing Chemist","summary":"Jazz Pharmaceuticals announces UK manufacturing investment - Manufacturing Chemist","headline":"Jazz Pharmaceuticals announces UK manufacturing investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOT21TQldKTXNSa2dqZnhPMVUwS3JNdmpEUzE1OUlKWHJMcHVUWmdZMVFFN1M2UjFhSkpZQ2pLZHZXaVVNQ09PUTE2RXh3ZTllelRtTUtocDNqdHJhNzlTNjhkQXdCaUNvYzU4YzE2ZFVjSk5XWVRIOUlJaVVuRXRkRUx4aExJN3M2bGtmUEZEcE9sakh4dVh1TV9vcVI1RDJpdXQ1M0FXX20?oc=5","date":"2021-09-16","type":"pipeline","source":"Fierce Biotech","summary":"Novo-backed Amolyt Pharma snags $80M series B for endocrine pipeline - Fierce Biotech","headline":"Novo-backed Amolyt Pharma snags $80M series B for endocrine pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOdFdPX25PcjRVRmlFbHRXNW0zNGtMNTRBT1VROS1UX0dtSWVPTWJuSzN5YlhBZjluYm9JMVlSYTg4YlEzcTUyZGhpOUtleFFtWmhZZ05seFcxeVloRDlBYXZ1bXBYeXp0a3o2QWF5a3ZoNmlfOUJoa3kyckdfMjNwbU5KOXlaaVdrOG1URVB1MmFCbmR6eUExZw?oc=5","date":"2020-02-28","type":"pipeline","source":"Life Science Leader","summary":"A Biopharma That Had To Pivot Twice To Forge Ahead - Life Science Leader","headline":"A Biopharma That Had To Pivot Twice To Forge Ahead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPUS1uNVJ4bU5ybm1qT0hsZzhMM3dIbDhHb0licGQwTEh6T3dzN2F2QmNCamZaNmhFOHE4a3hjUGpOcWRvYTVWUzA0ZTlXMVdfSjJneVJaZU05VEtKYkdOTmRobXBTZmdaSURCQWdRTFFSTFlrWWVhVWVqb3Z0aGQzZXYxX1NrQVU0Xzloalp2OA?oc=5","date":"2020-02-18","type":"pipeline","source":"Clinical Leader","summary":"A Small Biotech's 3 Steps To Recruitment Success - Clinical Leader","headline":"A Small Biotech's 3 Steps To Recruitment Success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE12RWw5dHM4M2NhS1luT3BHQWpvcXJiRXJIVllORkFhQ2xiYWx6b1RyMWZ0bkVUc2hhT1pzYUVMYVp6TER3S25TaFFuVXIwVWh2MVNIWmdkckREa0taUkc4VjBHeVZTdlhCbGM3aXd3?oc=5","date":"2019-07-10","type":"pipeline","source":"labiotech.eu","summary":"The Top 10 Biotechs You’ll Find in Lyon - labiotech.eu","headline":"The Top 10 Biotechs You’ll Find in Lyon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQY2ZXNUROQnNiWU9aWENkTm5fQTVzWnBldy03aUJKT29xcVRYazFNOWhRdXlQczYtOE1hNnBTMk91VTQ3OWs4MlY1YW9acHlCR1hJbEFtU3RXWEtpUWUxUEZla2hHSWlxUFgyV1d6VXhlTHItZDU0M1JrblkwMmRwV3FwdXdJc2V1ZW5MTTl4ZUpRdlpLZWxkdURkNU9XYnpiNUVjZUU5RTlBc3YxRmRvRVdIWTZ2STRsaHBjbWtxeGk1VS1Fcm5tbnNTMGJ4eEx6?oc=5","date":"2018-11-14","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Alizé Pharma 3 to Build Biopharmaceutical Company Focused on Rare Endocrine and Metabolic Diseases - drugdiscoverytrends.com","headline":"Alizé Pharma 3 to Build Biopharmaceutical Company Focused on Rare Endocrine and Metabolic Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPMGhxUUJRVmF2a2lGVHB1a01QT0p0QkxaZzdna2FmV0lKYm94bGxvX0NjSFZIcVlmWTlQLUJIT2x4bnJSWUIxcUJ0Tmx1Zno2MnNrYzlwSmM0c2hKclB1TU8ycThuVzZtLXN2RmxBcXY1SHFjMkxzYm44X2w1cmk0UjJWOFBoNURnZFFkR19ncjhuU0dlTUpCME43ZFoybTQ0UWFmRjhQOA?oc=5","date":"2018-03-01","type":"trial","source":"Prader-Willi Syndrome News","summary":"Alize’s AZP-531 Seen to Block Excessive Eating in Prader-Willi Syndrome in Clinical Trial - Prader-Willi Syndrome News","headline":"Alize’s AZP-531 Seen to Block Excessive Eating in Prader-Willi Syndrome in Clinical Trial - Prader","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQemplQWNOMk1iZEVvRG11ZWZIRnZGMjhKZUVaZ0hWRk1haE5mWHM5eHZlY3FpeFZidWJQb3dFdExybC1IZzF1RUVsT2dZSXBiUGtBX3RJSnAyX3JfcGVBSjR2NEh5MkI3R2pteThhTHlPcGx0bXBDbDFKSUtFaUNpemx4TndKTmpGN0o2UEpKYkFrckE?oc=5","date":"2017-12-28","type":"deal","source":"Contract Pharma","summary":"Millendo Therapeutics Acquires Alizé Pharma - Contract Pharma","headline":"Millendo Therapeutics Acquires Alizé Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNXy1TV1JocXBWMUNIX1AwSWotMGVPZHBnaS1YWlpJcGVJYUdsakdyanp5RUFmOTZ0eXVsT0YxWXFtbklEZkQwcUtTU05pRFZOTE5NQ3V1X2ZKeE1VcHFGc2N2RWVyMTlsMGhGNWVlSTkwY09JN19fZWEwSjYzcUFCOW9OTmMtaTZfVkFtV2xrYmhSeDEyeEJzUlFXendnT0hVZjM2dGZBVTlzOTdxTnRTSg?oc=5","date":"2016-04-28","type":"pipeline","source":"Fierce Biotech","summary":"Alizé to advance Prader-Willi drug following PhII completion - Fierce Biotech","headline":"Alizé to advance Prader-Willi drug following PhII completion","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}